59 results
Page 2 of 3
8-K
EX-99.1
kc94wrziur
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
8-K
EX-99.1
flcur434pu 548
4 Nov 21
Adaptimmune Reports Third Quarter Financial Results and Business Update
7:40am
8-K
EX-99.1
517h8u6mpok995acuo9
7 Sep 21
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
7:08am
8-K
EX-99.1
ftzk9yz8qx4ofjzu
9 Aug 21
Adaptimmune Reports Second Quarter Financial Results and Business Update
4:08pm
8-K
EX-99.1
e56qlxuvgv ncdlz
20 Nov 20
Regulation FD Disclosure
7:36am
8-K
EX-99.1
0rnkslrf05215n0rdn
27 Feb 20
Adaptimmune Reports Fourth Quarter / Full Year 2019 Financial Results and Business Update
7:39am
8-K
EX-99.1
ixmuyxk48ya6c93x1js9
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
8-K
EX-99.1
juahac5lw r7fw08a
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
ef3tjr
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-10.1
ffa1p1fvv0wi77
27 Aug 19
Entry into a Material Definitive Agreement
8:39am